Výsledky vyhledávání - "Woszczyk, D."

Akademický článek

The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age.

Autor: Tyczyńska A; Department of Hematology and Transplantology, Medical University of Gdańsk, 80-214 Gdańsk, Poland., Krzempek MK; Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland., Cortez AJ; Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland., Jurczyszyn A; Plasma Cell Dyscrasia Center, Department of Hematology, Jagiellonian University Medical College, 31-008 Kraków, Poland., Godlewska K; Department of Hematology, Medical University of Bialystok, M. Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland., Ciepłuch H; Copernicus Regional Oncology Center, 80-803 Gdansk, Poland., Subocz E; Department of Hematology, Military Institute of Medicine, 01-755 Warsaw, Poland., Hałka J; Department of Hematology, Military Institute of Medicine, 01-755 Warsaw, Poland., Kulikowska de Nałęcz A; Department of Hematology, State Hospital, 45-221 Opole, Poland., Wiśniewska A; Department of Oncology and Chemotherapy, Nicolas Copernicus State Hospital, 75-581 Koszalin, Poland., Świderska A; Department of Hematology, University Hospital of Karola Marcinkowski in Zielona Góra, 65-046 Zielona Góra, Poland., Waszczuk-Gajda A; Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland., Drozd-Sokołowska J; Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland., Guzicka-Kazimierczak R; Department of Hematology, Pomeranian Medical University, 70-204 Szczecin, Poland., Wiśniewski K; Department of Hematology, Institute of Hematology and Transfusion Medicine, 02-776 Warsaw, Poland., Porowska A; Department of Oncology and Hematology, Central Clinical Hospital, Ministry of the Interior, 01-150 Warsaw, Poland., Knopińska-Posłuszny W; Department of Hematology, Gdynia Oncology Center, 81-519 Gdynia, Poland., Kłoczko J; Department of Hematology, Medical University of Bialystok, M. Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland., Rzepecki P; Department of Hematology, Military Institute of Medicine, 01-755 Warsaw, Poland., Woszczyk D; Department of Hematology, State Hospital, 45-221 Opole, Poland., Symonowicz H; Department of Oncology and Chemotherapy, Nicolas Copernicus State Hospital, 75-581 Koszalin, Poland., Basak GW; Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland., Zdziarska B; Department of Hematology, Pomeranian Medical University, 70-204 Szczecin, Poland., Jamroziak K; Department of Hematology, Institute of Hematology and Transfusion Medicine, 02-776 Warsaw, Poland., Zaucha JM; Department of Hematology and Transplantology, Medical University of Gdańsk, 80-214 Gdańsk, Poland.

Publikováno v: Cancers [Cancers (Basel)] 2023 Jul 02; Vol. 15 (13). Date of Electronic Publication: 2023 Jul 02.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis.

Autor: Verstovsek S; The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Al-Ali HK; Krukenberg Cancer Center, University Hospital, Halle, 33790, Germany., Mascarenhas J; Icahn School of Medicine at Mount Sinai, NY 10029, USA., Perkins A; Australian Centre for Blood Diseases, Monash University, Victoria, 3294, Australia., Vannucchi AM; University of Florence, Florence, 50121, Italy., Mohan SR; Vanderbilt University Medical Center, Nashville, TN 37232, USA., Scott BL; Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Woszczyk D; Hematology Department, University of Opole, Opole, 45-040, Poland., Koschmieder S; Department of Hematology, Oncology, Haemostaseology & Stem Cell Transplantation (Department of Medicine IV), Faculty of Medicine, RWTH University Aachen, Aachen, 52062, Germany., García-Delgado R; Virgen de la Victoria University Hospital, Málaga, 29010, Spain., László R; Josa András Teaching Hospital, Nyíregyháza, 4400, Hungary., McGreivy JS; Kartos Therapeutics, Inc., Redwood City, CA 94065, USA., Rothbaum WP; Kartos Therapeutics, Inc., Redwood City, CA 94065, USA., Kiladjian JJ; Saint-Louis Hospital & Université Paris Cité, Paris, 75010, France.

Publikováno v: Future oncology (London, England) [Future Oncol] 2022 Nov 23. Date of Electronic Publication: 2022 Nov 23.

Zobrazit plný text záznamu

Akademický článek

Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML.

Autor: Adès L; INSERM U944, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Louis and University of Paris, Paris, France., Girshova L; Federal Almazov North-West Medical Research Centre, Saint-Petersburg, Russia., Doronin VA; City Clinical Hospital 40, Moscow, Russia., Díez-Campelo M; Institute for Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, Salamanca, Spain., Valcárcel D; Hematology Department, Vall Hebron Institute of Oncology (VHIO), Vall d'Hebron, University Hospital, Barcelona, Spain., Kambhampati S; Sarah Cannon at Research Medical Center, Kansas City, MO., Viniou NA; Hematology Unit, First, Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece., Woszczyk D; University of Opole, Provincial Hospital, Opole, Poland., De Paz Arias R; Hematology, Hospital Universitario La Paz-IDIPaz, Madrid, Spain., Symeonidis A; Hematology Division, Department of Internal Medicine, University Hospital Patras, Patras, Greece., Anagnostopoulos A; Hematology Department, General Hospital 'George Papanikolaou,' Thessaloniki, Greece., Munhoz EC; Hematology and Oncology Clinic, Erasto Gaertner Hospital, Curitiba, Brazil., Platzbecker U; Department of Hematology and Cellular Therapy, Leipzig University Hospital, Leipzig, Germany., Santini V; MDS (Myelodysplastic Syndrome) Unit, Hematology, Azienda Ospedaliero-Universitaria (AOU) Careggi, University of Florence, Florence, Italy., Fram RJ; Takeda Development Center Americas, Inc (TDCA), Lexington, MA; and., Yuan Y; Takeda Development Center Americas, Inc (TDCA), Lexington, MA; and., Friedlander S; Takeda Development Center Americas, Inc (TDCA), Lexington, MA; and., Faller DV; Takeda Development Center Americas, Inc (TDCA), Lexington, MA; and., Sekeres MA; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.

Publikováno v: Blood advances [Blood Adv] 2022 Sep 13; Vol. 6 (17), pp. 5132-5145.

Zobrazit plný text záznamu

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Autor: Mohty, M. Terpos, E. Mateos, M.-V. Cavo, M. Lejniece, S. Beksac, M. Bekadja, M.A. Legiec, W. Dimopoulos, M. Stankovic, S. Durán, M.S. De Stefano, V. Corso, A. Kochkareva, Y. Laane, E. Berthou, C. Salwender, H. Masliak, Z. Pečeliūnas, V. Willenbacher, W. Silva, J. Louw, V. Nemet, D. Borbényi, Z. Abadi, U. Pedersen, R.S. Černelč, P. Potamianou, A. Couturier, C. Feys, C. Thoret-Bauchet, F. Boccadoro, M. Bekadja, M. Hamladji, R.-M. Ali, H.A. Hamdi, S. Touhami, H. Mansour, N.S. Linkesch, W. Abildgaard, N. Hein, M. Eveillard, J.R. Yamani, A.E. Moreau, P. Sanhes, L. Lepeu, G. Laribi, K. Jourdan, E. Fitoussi, O. Allangba, O. Fleury, J. Escoffre, M. Benramdane, R. Cartron, G. Dine, G. Legouffe, E. Harich, H.-D. Illmer, T. Dörfel, S. Hannig, C.V. Koenigsmann, M. Prange-Krex, G. Tamm, I. Zeller, W. Maasberg, M. Schlag, R. Klausmann, M. Uhlig, J. Alkemper, B. Schütz, S. Tessen, H.-W. Mohr, B. Schmidt, P. Heinrich, B. Hebart, H. Seipelt, G. Zoeller, T. Heits, F. Müller-Naendrup, C. Hansen, R. Repp, R. Von Weikersthal, L.F. Schmits, R. Heßling, J. Krammer-Steiner, B. Janzen, V. Schauer, M. Grüner, M.W. Kisro, J. Denzlinger, C. Freier, W. Junghanss, C. Görner, M. Laichinger, K. Ostermann, H. Dürk, H. Hess, G. Reich, G. Matsouka, P. Pouli, A. Anagnostopoulos, A. Masszi, T. Ivanyi, J. Szomor, A. Nagler, A. Magen, H. Avivi, I. Quitt, M. Palumbo, A. Za, T. Vallisa, D. Foa, R. Bosi, A. Vacca, A. Lanza, F. Palazzo, G. Avvisati, G. Ferrara, F. Consoli, U. Cantonetti, M. Angelucci, E. Califano, C. Di Raimondo, F. Guarini, A. Musso, M. Pizzuti, M. Giuliani, N. Ardizzoia, A. Di Renzo, N. Gaidano, G. Gozzetti, A. Pitini, V. Farina, G. Centurioni, R. De Fabritiis, P. Iuliano, F. La Nasa, G. La Verde, G. Pane, F. Recine, U. La Targia, M. Mineo, G. Cangialosi, C. Fagnani, D. Federici, A. Romano, A. Specchia, G. Storti, S. Bongarzoni, V. Bacigalupo, A. Gobbi, M. Latte, G. Mannina, D. Capalbo, S. Jurgutis, M. Woszczyk, D. Hołojda, J. Gornik, S. Pluta, A. Morawiec-Szymonik, E. Kyrcz-Krzemien, S. Homenda, W. Grosicki, S. Sulek, K. Lange, A. Kloczko, J. Starzak-Gwozdz, J. Hellmann, A. Komarnicki, M. Kuliczkowski, K. Viveiros, C. Gonçalves, C. Esefyeva, N. Kaplanov, K. Volodicheva, E. Laricheva, E. Dergacheva, V. Chukavina, M. Volchenko, N. Nazarova, I. Anchukova, L. Ovanesova, E. Salogub, G. Magomedova, L. Kuznetsova, I. Osyunikhina, S. Serdyuk, O. Karyagina, E. Ivanova, V. Černelč, S.P. Coetzee, C. Gunther, K. Moodley, D. Duran, S. Gutiérrez, A.E. De Oteyza, J.P. Capote, F.J. Casanova, M. Sanchez, J.M. Rios-Herranz, E. Ibañez-Garcia, J. Herranz, M.J. Hernandez, B. Sanchez, S.S. Escalante, F. Carnicero, F. Lleonart, J.B. Gironella, M. Martínez, R. De La Guia, A.L. Palomera, L. Iglesias, R. Ramos, F.S. De La Serna, J. Sanchez, P.G. Vidal, J.B. Morfa, M.D. Beksac, T.-M. Vural, F. Aydin, Y. Unal, A. Goker, H. Bilgir, O. Guvenc, B. Turgut, M. Ozet, G.G. Ali, R. Kyselyova, M. Glushko, N. Vybyrana, R. Skrypnyk, I. Tretyak, N. Kharchevska, T. Dyagil, I. Popovs'ka, T. Shimanskiy, V. Lysa, T. Oliynyk, H. Vilchevskaya, K. Kryachok, I. Popovych, Y. Romanyuk, N. Yushchenko, N. Kaplan, P. Rekhtman, G. Pylypenko, H. Kozlov, V. Drach, J. Harousseau, J.-L. Einsele, H. Goldschmidt, H. Facon, T. Michalet, M. Savchenko, V.G. De la Rubia, J. Cook, G. Mellqvist, U.-H. Ludwig, H. EMMOS Investigators

Multiple myeloma (MM) remains an incurable disease, with little information available on its management in real-world clinical practice. The results of the present prospective, noninterventional observational study revealed great diversity in the tre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::121f2e22d1623bbbe181c3f9a1e47032
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3085843

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS) : a randomised, double-blind, phase 3 study

Autor: Chanan-Khan, Asher, Cramer, Paula, Demirkan, Fatih, Fraser, Graeme, Silva, Rodrigo Santucci, Grosicki, Sebastian, Pristupa, Aleksander, Janssens, Ann, Mayer, Jiri, Bartlett, Nancy L, Dilhuydy, Marie-Sarah, Pylypenko, Halyna, Loscertales, Javier, Avigdor, Abraham, Rule, Simon, Villa, Diego, Samoilova, Olga, Panagiotidis, Panagiots, Goy, Andre, Mato, Anthony, Pavlovsky, Miguel A, Karlsson, Claes, Mahler, Michelle, Salman, Mariya, Sun, Steven, Phelps, Charles, Balasubramanian, Sriram, Howes, Angela, Hallek, Michael, Assouline, S, Bence-Bruckler, I, Buckstein, R, Fraser, G, Larratt, L, Minuk, L, Villa, D, Angevine, A, Bartlett, N, Bixby, D, Caimi, P, Chanan-Khan, A, Craig, M, Forero-Torres, A, Ganguly, S, Goy, A, Heffner, L, Hermann, R, Lansigan, F, Leis, J, Letzer, J, Link, B, Liu, D, McCaul, K, McGuire, E, Skinner, W, Starodub, A, Stuart, R, Thirman, M, Tirumali, N, Yang, J, Janssens, A, Offner, F, Van den Neste, E, Van Hoof, A, Mayer, J, Novak, J, Trneny, M, Cartron, G, Dartigeas, C, Dilhuydy, M, Ghez, D, Haioun, C, Leblond, V, Salles, G, Balser, C, Cramer, P, Dreger, P, Durig, J, Eckart, M, Heinrich, B, Illmer, T, Jentsch-Ullrich, K, Pfreundschuh, M, Schetelig, J, Schlag, R, Soling, U, Stilgenbauer, S, Anagnostopoulos, A, Dimopoulos, A, Panagiotidis, P, Vrakidou, E, Bairey, O, Yehuda, D Ben, Braester, A, Fineman, R, Herishanu, Y, Nagler, A, Ruchlemer, R, Tadmor, T, Grosicki, S, Homenda, W, Jurczak, W, Pluta, A, Woszczyk, D, Espirito Santo, A, Luis, R, Raposo, J, Viveiros, C, Alexeeva, J, Dunaev, Y, Golubeva, M, Khuageva, N, Loginov, A, Lysenko, I, Osmanov, E, Pavlov, V, Pristupa, A, Proydakov, A, Rossiev, V, Samarina, I, Samoilova, O, Serduk, O, Shneider, T, Udovitsa, D, Voloshin, S, Gayoso, J, Gonzalez, M, Gonzalez Barca, E, Hernandez Rivas, J, Jargue, I, Loscertales, J, Karlsson, C, Sender, M, Aktan, M, Arslan, O, Demirkan, F, Ferhanoglu, B, Kaynar, L, Sayinalp, N, Vaural, F, Yagci, M, Dyagil, I, Kaplan, P, Masliak, Z, Oliynyk, H, Popovska, T, Pylypenko, H, Rekhtman, G, Dearden, C, Morley, N, Moss, P, Rule, S, Pavlovsky, M, Riveros, D, Santucci-Silva, R, Romeo, M, Scheliga, A, Salazar, L, Gomez, D, Ramirez, E, Jung, C

Most patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma relapse after initial therapy. Bendamustine plus rituximab is often used in the relapsed or refractory setting. We assessed the efficacy and safety of adding ibrutinib, an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe583710bcd15b107e94325ade65998
https://www.ncbi.nlm.nih.gov/pubmed/26655421

Zobrazit plný text záznamu

Akademický článek

Epigenetic-Based Therapy-A Prospective Chance for Medulloblastoma Patients' Recovery.

Autor: Strejczek A; Medical Faculty, Karol Marcinkowski University of Medical Sciences, Fredry 10, 61-701 Poznan, Poland., Woszczyk D; Medical Faculty, Karol Marcinkowski University of Medical Sciences, Fredry 10, 61-701 Poznan, Poland., Urbaniak H; Medical Faculty, Karol Marcinkowski University of Medical Sciences, Fredry 10, 61-701 Poznan, Poland., Różańska M; Medical Faculty, Karol Marcinkowski University of Medical Sciences, Fredry 10, 61-701 Poznan, Poland., Robak M; Medical Faculty, Karol Marcinkowski University of Medical Sciences, Fredry 10, 61-701 Poznan, Poland., Matuszewska Z; Medical Faculty, Karol Marcinkowski University of Medical Sciences, Fredry 10, 61-701 Poznan, Poland., Barciszewska AM; Intraoperative Imaging Unit, Chair and Clinic of Neurosurgery and Neurotraumatology, Karol Marcikowski University of Medical Sciences, Przybyszewskiego 49, 60-355 Poznan, Poland.; Department of Neurosurgery and Neurotraumatology, Heliodor Swiecicki Clinical Hospital, Przybyszewskiego 49, 60-355 Poznan, Poland.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2021 May 06; Vol. 22 (9). Date of Electronic Publication: 2021 May 06.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání